Mexico Dry Eye Medication Market Analysis

Mexico Dry Eye Medication Market Analysis


$ 3999

Mexico Dry Eye Medication Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of dry eye, aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medication market. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in Dry Eye Medication Market.

ID: IN10MXPH274 CATEGORY: Pharmaceuticals GEOGRAPHY: Middle East AUTHOR: Dr. Netal Patel

Buy Now

Mexico Dry Eye Medication Market Analysis Summary

Mexico Dry Eye Medication Market is valued at around $88.7 Mn in 2022 and is projected to reach $180.5 Mn by 2030, exhibiting a CAGR of 9.29% during the forecast period 2023-2030.

Dry eye disease, commonly known as dry eye syndrome or keratoconjunctivitis sicca, is a common eye illness characterized by insufficient or poor tear production. It happens when the eyes are unable to keep the ocular surface lubricated and moist. The increasing prevalence of dry eye, the aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medicine market. The drivers of the dry eye medicine market are an increasing prevalence of dry eye, an aging population, technological developments in drug formulations and diagnostics, increased awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in the Dry Eye Medication Market

Market Dynamics

Market Growth Drivers

  1. Increasing prevalence of dry eye: As the number of people experiencing dry eye symptoms grows, so does the demand for treatments
  2. Aging population: As the population ages, the prevalence of dry eyes rises, contributing to market expansion
  3. Technological innovations drive market growth by developing novel medicine formulations, delivery systems, and diagnostic instruments
  4. Increased awareness and diagnosis: Higher diagnostic rates and treatment-seeking behavior result from a better understanding of dry eye symptoms and increased awareness of potential therapies
  5. Lifestyle changes: Factors like increased screen time, air pollution, and contact lens wear contribute to the rising incidence of dry eye, creating a larger patient pool

Market Restraints

  1. Treatment choices are limited: Despite advances, there is still a need for more effective and targeted dry eye treatments
  2. Medication cost: The cost of dry eye drugs can be prohibitive for certain people
  3. Problems with adverse effects and tolerability: Some drugs may have side effects or be intolerable, affecting patient acceptance and compliance
  4. Underdiagnosis and undertreatment: Many people with dry eyes may not seek medical assistance, resulting in underdiagnosis and undertreatment

Competitive Landscape

Key Players

  • Allergan plc (AbbVie Inc.)
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Alcon, Inc. (a division of Novartis AG)
  • Sun Pharmaceutical Industries Ltd.
  • Otsuka Holdings Co.
  • Taisho Pharmaceutical Co., Ltd
  • Senju Pharmaceutical Co.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Mexico Dry Eye Medication Market Segmentation

By Drug Class

  • Artificial Tears
  • Anti-inflammatory Drugs
  • Immunosuppressants
  • Others

By Product Type

  • Prescription Based
  • Over-the-counter

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up